AbbVie Inc. (ABBV) vs Johnson & Johnson (JNJ)
AbbVie Inc. and Johnson & Johnson are both Drug Manufacturers General companies. Johnson & Johnson is the larger, with a market value of $652.8B against $467.4B — 1.4× the size. Johnson & Johnson trades at the lower P/E: 31.4× against 74.7×. AbbVie Inc. grew revenue faster over the last twelve months: 10.4% against 8.06%. Johnson & Johnson has the higher net margin (21.5% vs 9.74%) and the lower return on invested capital (15.5% vs 18.1%). Both pay a dividend; AbbVie Inc. yields more (3.57% vs 3.07%). Across the 22 metrics below, Johnson & Johnson leads on 13 and AbbVie Inc. on 9.
Valuation
Profitability
| Metric | ABBV | JNJ | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 71.48% | 67.91% | 72.77% |
| Operating margin | 26.20% | 27.69% | 18.90% |
| Net margin | 9.74% | 21.48% | 8.27% |
| Free cash flow margin | 28.28% | 23.20% | 17.25% |
| Return on equity | (208.10%) | 25.74% | 6.97% |
| Return on assets | 4.61% | 10.67% | 2.76% |
| Return on invested capital | 18.07% | 15.51% | 6.30% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack